Dehydrated Alcohol Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: ≥99% ethyl alcohol
Reference Brands: ABLYSINOL (USA)
Category: Heart Disorder
Dehydrated Alcohol is available in Injection and strengths such as ≥99% ethyl alcohol. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Dehydrated Alcohol is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Dehydrated Alcohol can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
ABLYSINOL® is a sterile dehydrated alcohol (ethyl alcohol) injection indicated for the treatment of adults with symptomatic hypertrophic obstructive cardiomyopathy (HOCM) who are not suitable candidates for surgical myectomy. It works by inducing a controlled cardiac septal infarction, reducing obstruction in the left ventricular outflow tract and thereby improving exercise capacity and relieving symptoms such as shortness of breath and chest discomfort. The active component, dehydrated alcohol (≥99%), is delivered via intra-arterial injection into the septal branches of the coronary artery under the guidance of an experienced interventional cardiologist. This procedure creates localized tissue necrosis in the hypertrophied septum, which leads to a reduction in septal thickness and improvement in cardiac function over time. ABLYSINOL is supplied in single-dose vials or ampules of 1 mL and 5 mL, ensuring precise dosing for controlled administration. The product is manufactured by BPI Labs, LLC in the United States and is intended for use only in specialized cardiac centers with appropriate monitoring and supportive measures, due to potential risks such as arrhythmias or transient heart block. ABLYSINOL provides a minimally invasive therapeutic option for patients with HOCM who cannot undergo surgery.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
ABLYSINOL is used in interventional cardiology to induce controlled myocardial tissue necrosis during alcohol septal ablation for patients with symptomatic hypertrophic obstructive cardiomyopathy who are not suitable candidates for surgical myectomy.
ABLYSINOL is made from dehydrated alcohol, which is the complete chemical form of ethyl alcohol, present at a concentration of not less than 99%.
ABLYSINOL is the trade (brand) name under which dehydrated alcohol injection is marketed for medical use.
ABLYSINOL is manufactured and marketed by BPI Labs, LLC in the United States.
The generic name of ABLYSINOL is dehydrated alcohol (ethyl alcohol).
The brand name of dehydrated alcohol injection used for septal ablation is ABLYSINOL.
ABLYSINOL is manufactured in the United States by BPI Labs, LLC for clinical use in specialized cardiac procedures.
Related Products
Acebutolol Hydrochloride
Strength:
200 mg, 400 mg
Form: Capsules
Reference Brands: Sectral (USA)
View Details
Nicardipine Hydrochloride
Strength:
20 mg, 30 mg, 40 mg, 2.5 mg/mL
Form: Capsules / Injection
Reference Brands: Cardene (USA),
View Details
Nadolol
Strength:
20 mg, 40 mg, 80 mg,160 mg
Form: Tablets
Reference Brands: Corgard (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
